Dysregulation of the PRL/vasoinhibin axis has been brought into context with diabetic retinopathy, retinopathy of prematurity (9, 15, 16), preeclampsia, and pregnancy-induced hypertension (10, 17–21). The gene discussed is PRL; the disease is retinopathy of prematurity.